Problem: Others have argued that excessive regulation suppresses therapeutic innovation, and that the current cost of regulator-required clinical trials prevents the full exploitation of new genetic and biological knowledge for the treatment of human disease. A 2012 report by the President's Council of Advisors on Science and Technology made several key recommendations to reduce regulatory burdens to new drug development, including 1) expanding the FDA's use of accelerated approval processes, 2) creating an expedited approval pathway for drugs intended for use in narrowly defined populations, and 3) undertaking pilot projects designed to evaluate the feasibility of a new, adaptive drug approval process.
What is excessive drug regulation said to suppress?
---
Answer: therapeutic innovation

Problem: Most elevators have a location in which the permit for the building owner to operate the elevator is displayed. While some jurisdictions require the permit to be displayed in the elevator cab, other jurisdictions allow for the operating permit to be kept on file elsewhere such as the maintenance office and to be made available for inspection on demand. In such cases instead of the permit being displayed in the elevator cab, often a notice is posted in its place informing riders of where the actual permits are kept.
What type of notice can be displayed in the elevator in lieu of the permit?
---
Answer: a notice is posted in its place informing riders of where the actual permits are kept.

Problem: In 2008, State Council established a counterpart support plan (). The plan is to arrange 19 eastern and central province and municipalitie to help 18 counties, on "one province to one affected county" basis. The plan spanned 3 years, and cost no less than one percent of the province or municipality's budget.
What did the State Council establish in 2008?
---
Answer:
a counterpart support plan